Beta Bionics BBNX Institutional Ownership

Updated Oct 11, 2026

Beta Bionics, Inc. (NASDAQ:BBNX) was held by 134 institutional investors that filed 13F reports for the quarter ended June 30, 2026.

• Total holdings of Beta Bionics shares fell 2.59% from Q1 2026, and the number of holders rose 18.58% from Q2 2025.
• Looking at the 134 holders of BBNX individually, 85 added to their positions, 36 reduced their stakes and 13 left their positions unchanged.
• In total, institutional investors held 47.93Mn shares of Beta Bionics at the end of Q2 2026, down 1.28Mn from the prior quarter and up 6.57Mn from a year earlier.
• Eventide Asset Management, LLC held the largest position in BBNX at 6.25Mn shares as of June 30, 2026.
• Holders that added the most shares of Beta Bionics in Q2 2026 were Goldman Sachs Group Inc (+415.77K shares), Bank of America Corp (+410.44K shares), JPMorgan Chase & Co (+396.13K shares), Eventide Asset Management, LLC (+308.19K shares) and BlackRock, Inc. (+301.58K shares).
• Among holders that kept a stake in Beta Bionics, the biggest sellers in Q2 2026 were Farallon Capital Management, L.L.C. (-3.01Mn shares), Vestal Point Capital, LP (-611.52K shares), RTW Investments, LP (-500K shares), Y-Intercept (Hong Kong) Ltd (-422.81K shares) and Point72 Asset Management, L.P. (-270.36K shares).
• Per Business Quant data, the 10 largest holders of Beta Bionics at the end of Q2 2026 were Eventide Asset Management, LLC (6.25Mn shares), Soleus Capital Management, L.P. (4.39Mn shares), Morgan Stanley (4.27Mn shares), Sands Capital Alternatives, LLC (3.71Mn shares), BlackRock, Inc. (3.34Mn shares), Point72 Asset Management, L.P. (2.25Mn shares), Vanguard Capital Management LLC (1.78Mn shares), Vestal Point Capital, LP (1.6Mn shares), RTW Investments, LP (1.5Mn shares) and Deerfield Management Company, L.P. (1.32Mn shares).